Product image of Improzol (Omeprazole) supplied by GNH India

Improzol

Active Ingredient:
Omeprazole
Origin:
EU

Improzol (Omeprazole)

Omeprazole, the active ingredient in Improzol, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders in adults and children when appropriate.

GNH India supplies Improzol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Industria Química Y Farmaceútica Vir, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Improzol (omeprazole) acts on the gastric proton pump to lower acid production, addressing conditions driven by excess gastric acidity.

  • Gastroesophageal reflux disease (GERD): relieves heartburn, regurgitation and esophagitis by decreasing acid exposure.
  • Peptic ulcer disease: promotes ulcer healing and prevents recurrence by maintaining a less acidic gastric environment.
  • Helicobacter pylori eradication regimens: enhances antibiotic effectiveness when used as part of combination therapy.
  • Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

How It Works

  • Omeprazole irreversibly binds to the H+/K+ ATPase enzyme (proton pump) located on the secretory surface of gastric parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH and facilitating healing of acid‑related lesions.

Side Effects

Improzol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Headache: mild to moderate intensity, often resolves without intervention.
  • Diarrhea: loose stools that may improve with continued therapy.
  • Nausea: occasional feeling of queasiness after dosing.
  • Abdominal pain: mild discomfort in the upper abdomen.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
  • Acute interstitial nephritis: renal inflammation that may cause reduced urine output.
  • Hypersensitivity reactions: rash, angioedema or anaphylaxis requiring immediate medical attention.

Precautions & Warnings

Before initiating Improzol, consider the following safety measures.

  • Assess renal and hepatic function: dose adjustment may be needed in severe impairment.
  • Review long‑term use: prolonged therapy can increase risk of fractures and vitamin B12 deficiency.
  • Monitor for infection: reduced gastric acidity may predispose to gastrointestinal infections.
  • Evaluate drug interactions: especially with clopidogrel, atazanavir and HIV protease inhibitors.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet activation may diminish efficacy.
  • Atazanavir: decreased absorption leading to subtherapeutic antiviral levels.
  • HIV protease inhibitors (e.g., ritonavir): increased plasma concentrations may raise toxicity risk.

Moderate Interactions (Monitor Closely)

  • Digoxin: higher serum levels may occur; monitor concentrations.
  • Methotrexate: reduced clearance can enhance toxicity; adjust dose if needed.
  • Phenytoin: omeprazole may increase phenytoin levels; observe for signs of toxicity.

Frequently Asked Questions

Improzol contains omeprazole, a proton pump inhibitor used to lower stomach acid. It is prescribed for conditions such as gastroesophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens, and Zollinger‑Ellison syndrome, helping to relieve symptoms and promote healing of acid‑related lesions.

Omeprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. By irreversibly inhibiting this pump, it suppresses the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose of Improzol is determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Dosage regimens may vary for short‑term versus long‑term treatment and should be followed exactly as directed on the prescription label.

Safety data for omeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To order Improzol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Improzol (omeprazole) belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may differ.

Improzol should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight, and ensure the packaging remains tightly closed until use.

Improzol is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, often in the morning, unless the prescriber advises a different schedule.

Serious but rare risks include Clostridioides difficile‑associated diarrhea, acute interstitial nephritis, and severe hypersensitivity reactions such as rash, angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience persistent diarrhea, unexplained swelling, or signs of an allergic reaction.

Improzol is contraindicated in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking medications that have major interactions (e.g., clopidogrel, atazanavir), and patients with a history of allergic reactions to proton pump inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT